BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 10546001)

  • 1. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
    Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
    Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.
    Hamid T; Malik MT; Kakar SS
    Mol Cancer; 2005 Jan; 4(1):3. PubMed ID: 15649325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of estrogen in pituitary tumor pathogenesis.
    Heaney AP; Fernando M; Melmed S
    J Clin Invest; 2002 Jan; 109(2):277-83. PubMed ID: 11805140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas.
    Chamaon K; Kanakis D; Mawrin C; Dietzmann K; Kirches E
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):121-6. PubMed ID: 19472104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).
    Zhang X; Horwitz GA; Prezant TR; Valentini A; Nakashima M; Bronstein MD; Melmed S
    Mol Endocrinol; 1999 Jan; 13(1):156-66. PubMed ID: 9892021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lung cancer with siRNA targeting PTTG.
    Kakar SS; Malik MT
    Int J Oncol; 2006 Aug; 29(2):387-95. PubMed ID: 16820881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
    Maeda T; Lloyd RV
    Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of pituitary tumor-transforming gene in endometrial carcinoma].
    Wang YK; Cui N; Li J; Luo B
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):538-42. PubMed ID: 15363353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas.
    Honda S; Hayashi M; Kobayashi Y; Ishikawa Y; Nakagawa K; Tsuchiya E
    Anticancer Res; 2003; 23(5A):3775-82. PubMed ID: 14666677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
    Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice.
    El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS
    J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
    Zhu X; Asa SL; Ezzat S
    Clin Cancer Res; 2008 Apr; 14(7):1984-96. PubMed ID: 18381936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.
    Salehi F; Kovacs K; Scheithauer BW; Lloyd RV; Cusimano M
    Endocr Relat Cancer; 2008 Sep; 15(3):721-43. PubMed ID: 18753362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and IGF-1 regulate the expression of the pituitary tumor transforming gene (PTTG) in breast tumor cells.
    Thompson AD; Kakar SS
    FEBS Lett; 2005 Jun; 579(14):3195-200. PubMed ID: 15922332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of pituitary tumors.
    Yu R; Melmed S
    Prog Brain Res; 2010; 182():207-27. PubMed ID: 20541667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
    Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
    Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.